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ABSTRACT
RACETTE, S. B., J. ROCHON, M. L. UHRICH, D. T. VILLAREAL, S. K. DAS, L. FONTANA, M. BHAPKAR, C. K. MARTIN, L. M.
REDMAN, P. J. FUSS, S. B. ROBERTS, and W. E. KRAUS. Effects of Two Years of Calorie Restriction on Aerobic Capacity and
Muscle Strength. Med. Sci. Sports Exerc., Vol. 49, No. 11, pp. 2240–2249, 2017. Purpose: Calorie restriction (CR) improves health
span and delays age-related diseases in many species. The multicenter Comprehensive Assessment of Long-term Effects of Reducing Intake
of Energy (CALERIE) study was the first randomized controlled trial of CR in nonobese humans. The aim of this investigation was to
determine the effects of CR on V˙O2max and muscle strength in the CALERIE trial. Methods: Healthy, normal-weight, and mildly
overweight women and men (n = 218, mean T SE age = 37.9 T 0.5 yr) were randomized to 25% CR or an ad libitum (AL) control
condition in a 2:1 allocation (143 CR, 75 AL). V˙O2max was determined with an incremental treadmill test; the strength of the knee flexors
and extensors was assessed by dynamometry at baseline, 1 yr, and 2 yr. Results: The CR group achieved an average 11.9% T 0.7% CR
during the 2-yr intervention. Body weight decreased in CR (j7.7 T 0.4 kg), but not AL (+0.2 T 0.5 kg). Absolute V˙O2max (LImin
j1)
decreased at 1 and 2 yr with CR, whereas V˙O2max expressed relative to body mass increased at both time points (1 yr: +2.2 T 0.4; 2 yr: +1.9 T
0.5 mLIkgj1Iminj1) and relative to AL. The CR group increased their treadmill test time and workload at 1 and 2 yr. Strength results in
CR were similar, with decreases in absolute flexor and extensor strength, but increases when expressed relative to body mass. No changes
were observed for V˙O2max expressed relative to lean body mass or leg lean mass. Conclusions: Two years of modest CR without a
structured exercise component did not appear to compromise aerobic capacity in healthy nonobese adults. The clinical implications of the
observed changes in V˙O2max and muscle strength will be important to explore in future studies. Key Words: V˙O2max, CR, ENDUR-
ANCE, CARDIORESPIRATORY FITNESS
C
alorie restriction (CR), characterized by a reduction
in energy intake without nutrient deficiency, has
been shown to extend health span and life span in a
variety of organisms, including nonhuman primates (19).
CR is the only known intervention that affects both primary
aging (i.e., the inevitable age-related deterioration in tissue
structure and function) and secondary aging (i.e., deteriora-
tion in tissue structure and function due to adverse lifestyle
and environmental factors) (13). A series of observational
human studies of adults who have been following a CR diet
voluntarily for several years provides intriguing evidence
that CR has many health benefits in nonobese humans (7)
that are similar to those observed in experimental animal and
rodent models. CR is a promising intervention that may
enhance cardiovascular health in humans (3).
However, in addition to promoting fat oxidation that causes
reductions in adipose tissue with related metabolic health
benefits, CR generally induces loss of lean body mass (21,23)
because of the catabolism of skeletal muscle and myocardial
tissue. There is also some evidence that prolonged CR in
humans results in lower physical activity (18), whereas CR in
animal models results in preservation of or even increases
in physical activity (32). Collectively, these effects of CR on
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muscle mass and muscle activity in humans may cause ad-
verse changes in cardiorespiratory fitness and muscle strength.
On the basis of the well-established association of higher
cardiorespiratory fitness and reduced mortality (27), an inter-
vention that adversely affects cardiorespiratory fitness may be
cause for concern.
The Comprehensive Assessment of Long-term Effects of
Reducing Intake of Energy (CALERIE) study was the first
randomized controlled trial of prolonged CR in humans (25).
In the CALERIE phase 1 study, we observed that 1 yr of CR
in a middle-age (50–60 yr) cohort of nonobese men and
women caused reductions in lean body mass, thigh muscle
volume, absolute muscle strength, and absolute maximal oxy-
gen uptake (V˙O2max) (30). However, when V˙O2max and muscle
strength were expressed relative to whole body mass, lean
body mass, or muscle volume, the reductions from baseline
were no longer significant. Whether the absolute decrements
in aerobic capacity and strength in response to CR are clini-
cally important is unclear. Furthermore, it is unknownwhether
nonobese younger adults would demonstrate similar decre-
ments in muscle mass, strength, and aerobic capacity during
long-term CR.
As part of the CALERIE 2 multicenter study, which ex-
plored the effects of 2 yr of CR on various metabolic, physi-
ological, and psychological outcomes in healthy young and
middle-age adults (22,25), we sought to determine whether
long-term CR adversely affects aerobic capacity and muscle
strength in normal weight and mildly overweight individuals.
METHODS
Overview. The CALERIE 2 study was a multicenter, ran-
domized controlled trial of 2 yr of CR versus an ad libitum
(AL) control condition. The design and primary outcomes of
the study have been described in detail elsewhere (22,25). The
focus of the current analysis is on aerobic capacity and strength
measures, which were assessed at baseline, 1 yr, and 2 yr.
Subjects. Participants were enrolled at three clinical
CALERIE sites: Pennington Biomedical Research Center, Baton
Rouge, LA; Tufts University, Boston, MA; and Washington
University School ofMedicine, St. Louis,MO. Eligibility criteria
included bodymass index (BMI) of 22.0 to G28.0 kgImj2, age
21–47 yr for women (to avoid menopause) and 21–50 yr for
men, nonsmoking, absence of chronic diseases, low risk for
eating disorders, and willingness to be randomized to an in-
tervention or control group for 2 yr. An exclusion criterion
was engagement in a regular exercise program of vigorous
physical activity for Q30 min five or more times per week
during the past year. After a series of screening assessments
and interviews, eligible participants were randomly assigned
to the CR intervention or to an AL control group in a 2:1
ratio, with stratification for site, sex, and BMI (i.e., BMI
G25.0 vs Q25.0 kgImj2). The CR intervention and all study
procedures were uniform across the three study sites, and the
protocol was approved by the Institutional Review Board at
each site. Safety was monitored throughout the trial by a data
and safety monitoring board. All participants provided written
informed consent.
CR intervention. The CR prescription was set at 25%;
the goal was to reduce daily energy intake by 25% relative to
daily energy expenditure at baseline and to maintain that
intake level for 2 yr. Baseline energy expenditure was de-
termined using the doubly labeled water method during two
consecutive 2-wk periods (i.e., 4 wk) of weight stability
(22). Thus, the specific calorie prescription was individual-
ized for each participant. The composition of the CR diet
was flexible to accommodate individual preferences. During
the first 27 d of the 2-yr intervention, participants received
three diets (9 d each) of differing macronutrient composi-
tion, prepared in the metabolic kitchen at each study site.
This strategy promoted early adherence and familiarity with
25% CR using different dietary approaches. Extensive edu-
cation, counseling, encouragement, and support were pro-
vided by registered dietitians, psychologists, and licensed
behavior counselors through a structured intervention deliv-
ered through a combination of individual and group sessions
to facilitate adherence (24). Individual sessions were held
weekly (during month 1), twice per month (months 2–12),
and monthly (months 13–24); group sessions occurred twice
monthly (months 1–6) and monthly (months 7–24). There was
no exercise intervention, and no efforts were made to alter par-
ticipants’ physical activity levels (PAL). However, all CALERIE
participants (CR and AL) were informed about the Centers for
Disease Control and Prevention’s physical activity guidelines,
which at that time recommended at least 30 min of moderate
intensity physical activity on at least 5 dIwkj1.
AL control group. Participants in the AL group were
instructed to continue their habitual dietary patterns; they did
not receive education or counseling from research personnel
beyond instructions needed to complete food diaries and
physical activity questionnaires. AL group participants com-
pleted the same assessments as participants in the CR group.
Whole body mass, lean body mass, and leg lean
mass. Whole body mass was measured to the nearest 0.1 kg
on a calibrated scale (Scale Tronix 5200, White Plains, NY) in
the research centers in the morning in the fasted state, with the
participant wearing a preweighed hospital gown. Lean body
mass and leg lean mass were assessed by dual-energy x-ray
absorptiometry (DXA; Hologic Inc., Bedford, MA) using a
standardized protocol to ensure consistent subject positioning
and scan mode over time and across the three clinical sites.
Analyses of all DXA scans were performed using Hologic
software (Apex version 3.3) at the CALERIE DXA reading
center (University of California, San Francisco). The average
lean mass of the right and left legs was used in the muscle
strength analyses.
Physical activity energy expenditure. Energy expended
in physical activity was estimated from total daily energy ex-
penditure (TDEE), resting metabolic rate (RMR), and thermic
effect of food (TEF) using the following formula: activity
energy expenditure (AEE) = TDEE j RMR j TEF. TDEE
was assessed during 4 wk at baseline and for 2 wk at the 1- and







2-yr time points using the doubly labeled water method. RMR
was assessed by indirect calorimetry with a calibrated Vista-
MX metabolic cart (Vacumed, Ventura, CA). TEF was esti-
mated to be 10% of daily energy intake. At baseline, energy
intake was assumed to equal TDEE because participants were
weight stable; at the 1- and 2-yr time points, energy intake was
computed from TDEE and changes in body energy stores
based on DXA (20). PAL was computed as TDEE/RMR and
used as a relative estimate of physical activity (16) as subjects
lost weight.
Dietaryprotein intake. Daily protein intake was quantified
from 6-d food diaries that were analyzed using the University of
Minnesota Nutrition Data System for Research dietary analysis
program at the CALERIE nutrition reading center (University of
Cincinnati). Protein intake was expressed in absolute (gIdj1)
and relative (gIkg body massj1Idj1) quantities.
Aerobic capacity and physiologic responses to
maximal treadmill exercise. Maximal oxygen uptake
(V˙O2max) was measured using the Cornell incremental tread-
mill test (28), with the speed and/or grade of the treadmill
changing every 2 min (stage 1, 1.7 mph/5% grade; stage 2,
1.7 mph/10%; stage 3, 2.0 mph/10%; stage 4, 2.5 mph/12%;
stage 5, 3.0 mph/13%; stage 6, 3.4 mph/14%; stage 7, 3.8 mph/
16%; stage 8, 4.2 mph/16%; stage 9, 4.8 mph/17%; stage 10,
5.0 mph/17%; stage 11, 5.0 mph/18%; stage 12, 5.5 mph/
18%). Expired gases were collected continuously, and venti-
latory variables were calculated at 15-s intervals using a cali-
brated metabolic cart (TrueOne 2400 or TrueMax 2400;
Parvo Medics, Sandy, UT). The flowmeter was calibrated
with a 3-L syringe, and gas calibration was performed with
precision-analyzed gas mixtures before and after each test.
Participants were instructed not to take medications the morn-
ing of the assessment and not to eat or drink beverages other
than water for at least 90 min before their treadmill test. Before
the baseline test, participants practicedwalking on the treadmill
without holding onto the handrails. Before each test, partici-
pants were familiarized with the testing protocol, the Borg RPE
scale (4), and hand signals. HR was monitored continuously
throughout the test with 12-lead ECG. Blood pressure (BP)
was measured by auscultation at every other workload and at
the end of the test. RPE was recorded during the last 30 s of
each workload. Research personnel provided verbal encour-
agement and support to assist participants in reaching a max-
imal effort.
The two highest consecutive 15-s V˙O2 values during the
last 2 min of exercise were averaged to determine V˙O2max if
the following three criteria were met: a plateau in V˙O2, de-
fined as an increase of e150 mL between the final two
workloads (i.e., stages) of the test, RER Q 1.10, and HRmax
within 10 bpm of age-predicted HRmax. Age-predicted HRmax
was computed as 208 j (0.7  age) (29). Oxygen pulse at
maximal exercise was calculated as absolute V˙O2max divided
by HRmax. Rate pressure product at maximal exercise was
computed as the product of HRmax and maximal systolic BP.
Muscle strength and muscle endurance. Muscle
strength and endurance were assessed for knee extensors and
knee flexors using Biodex System 3 dynamometers (Biodex
Medical Systems, Shirley, NY) at all three sites; a Cybex II
Isokinetic Dynamometer (Cybex Division of Lumex, Inc.,
Ronkonkoma, NY) was used with some participants at the
Pennington Biomedical Research Center. The test sequence
and procedures were standardized and programmed into the
dynamometers. Personnel at all sites followed the same script
for explaining the assessments to participants. The V˙O2max
and strength tests were performed 1 wk apart at approxi-
mately the same time of day at all assessment time points.
The testing series began with a 10-min warm-up on a
cycle ergometer (50 W, 70 rpm). The participant was then
positioned properly in the dynamometer chair, and the right
leg was weighed at 30-. All results were adjusted (by the
dynamometer computer) for gravity effect by subtracting the
lower leg mass from flexion torque values and adding lower
leg mass to extension torque values. Subjects were familiarized
with the testing procedures by performing three submaximal
repetitions (~75% effort) at each angular velocity. The iso-
kinetic strength tests included five repetitions of concentric
knee extension and concentric knee flexion at 60-Isj1, then at
180-Isj1, with a 30-s rest between sets. After a 5-min rest
period, muscular endurance was assessed using 30 repetitions
of concentric knee extension and flexion at 180-Isj1. Partic-
ipants were instructed to contract maximally with each repe-
tition rather than to pace themselves. After another 5-min rest
period, three 5-s maximal isometric contractions, with a 30-s
rest between, were performed at 45- for knee extension and
flexion. Within a set, all repetitions were performed contin-
uously, without rest between repetitions. The entire sequence
was repeated with the left leg.
Muscular strength was interpreted as peak torque from the
isokinetic and isometric tests. Results of the right and left
legs were averaged and expressed in absolute terms, relative
to whole body mass, and relative to leg lean mass. Muscular
endurance was determined from muscle fatigue index, which
was computed for both knee extension and knee flexion as
the percent decrease in peak torque during the 30-repetition
isokinetic sets at 180-Isj1 using the following equation:
muscle fatigue index ¼ 100j mean of last 5 repetitions
mean of highest consecutive 5 repetitions
 100
Results from the right and left legs were averaged. A
composite muscle fatigue index was computed for knee
extension and flexion by averaging those results.
Statistical analyses. Standard intention-to-treat anal-
yses were performed by including all available observations
for each time point. Baseline characteristics were compared
using the Wilcoxon–Mann–Whitney test for continuous and
ordinal variables. Typical for outcomes dependent on maxi-
mal exertion, an initial examination of outcome variables re-
vealed numerous outliers. Because of concerns that they could
exert undue influence on the results, robust regression pro-
cedures (15) were used to evaluate responses to CR. Specif-
ically, M-estimation (14) using the bisquare weight function










as implemented in PROC ROBUSTREG in SAS was applied.
The advantage is that this method is nearly fully efficient when
the data are normally distributed yet provides resistant and
stable inference in the presence of outliers. The dependent
variable was the change from baseline to 1 yr or 2 yr, with
treatment assignment as the between-group factor. Design
variables (i.e., site, sex, and BMI stratum) and the baseline
value centered about the mean of the outcome were included
as covariates. The predicted mean and SE are the adjusted
values from this model. Within- and between-group changes
from baseline were tested by defining contrasts among the
regression parameters. Type I error was controlled at > = 0.05
using the sequentially rejective Bonferroni procedure (12);
P values were adjusted using the method of Wright (31).
Consistency between the two sexes was evaluated by adding
and testing the treatment–sex interaction term. Spearman
correlations were used to determine univariate associations.
Analyses were performed using SAS Software version 9.2
and higher (SAS Institute, Cary, NC). Data are expressed as
means T SE.
RESULTS
Subjects. As reported in detail previously (22), 218 sub-
jects began the study (143 CR, 75 AL); 69.7% were women.
The racial distribution was 77.1% White, 11.9% Black, and
11.0% other; 3.2% were Hispanic.Mean age was 37.9 T 0.5 yr.
Attrition during the 2-yr study resulted in an analysis sample of
201 subjects (130 CR, 71 AL) at 1 yr and 188 subjects (117 CR,
71 AL) at 2 yr. The CR group achieved an average 11.9% T
0.7% CR during the 2-yr intervention, which was significantly
lower than the prescribed 25% CR. No sex differences were
observed in the average %CR achieved during year 1 (females,
15.1% T 0.8%; males, 15.3% T 1.2%; P = 0.74) or throughout
the 2-yr intervention (females, 11.9% T 0.8%; males, 11.7% T
1.2%; P = 0.85).
Whole body mass, lean body mass, and leg lean
mass. At baseline, 48% of subjects were categorized as
normal weight (i.e., BMI, 22.0 to G25.0 kgImj2) and 52%
were overweight (i.e., BMI, 25.0 to G28.0 kgImj2). As
shown in Table 1, whole body mass decreased significantly
in the CR group, but not in the AL group, at 1 and 2 yr, with
a significant difference between groups at both time points.
Likewise, lean body mass and leg lean mass decreased in
response to the CR intervention. There was a significant
correlation between change in whole body mass and change
in lean body mass in the CR group at 2 yr (r = 0.649, P G
0.0001). Comprehensive analyses of body composition changes
by treatment and sex are provided by Das et al. (6).
Physical AEE. Absolute AEE (kcalIdj1) decreased sig-
nificantly in the CR group at 1 and 2 yr (Table 1). In the CR
group, this tended to differ by sex (P = 0.055), with decreases
observed in females (j129 T 23 andj142 T 26 kcalIdj1 at 1
and 2 yr, respectively, both P G 0.0001), but not in males (P =
0.701). When physical activity was expressed in relative
terms as PAL, no significant changes were observed in the
CR or AL group.
Dietary protein intake. Absolute protein intake (gIdj1)
did not differ between groups (Table 1). Relative protein in-
take exceeded the recommended dietary allowance of 0.8 gIkg
bodymassj1Idj1 (16) throughout the intervention. The change
in lean body mass in the CR group from baseline to 2 yr was
TABLE 1. Body mass, physical activity, and dietary protein in the CR and AL groups.
CR AL
Mean T SE Within-Group P Value Mean T SE Within-Group P Value Between-Group P Value
Body mass (kg)
Baseline 72.0 T 0.8 71.5 T 1.1 0.978
Change at 1 yr j8.5 T 0.3 G0.0001 j0.4 T 0.4 0.529 G0.0001
Change at 2 yr j7.7 T 0.4 G0.0001 +0.2 T 0.5 0.688 G0.0001
Lean body mass (kg)
Baseline 46.0 T 0.8 45.2 T 1.0 0.479
Change at 1 yr j2.2 T 0.1 G0.0001 j0.2 T 0.2 0.439 G0.0001
Change at 2 yr j2.3 T 0.2 G0.0001 j0.1 T 0.2 0.533 G0.0001
Leg lean mass (kg)
Baseline 7.7 T 0.1 7.5 T 0.2 0.302
Change at 1 yr j0.36 T 0.03 G0.0001 +0.01 T 0.03 0.813 G0.0001
Change at 2 yr j0.41 T 0.03 G0.0001 j0.01 T 0.04 0.813 G0.0001
Physical AEE (kcalIdj1)
Baseline 808 T 20 758 T 27 0.183
Change at 1 yr j64 T 21 0.010 j8 T 27 0.876 0.244
Change at 2 yr j84 T 23 0.002 j5 T 29 0.876 0.105
PAL
Baseline 1.75 T 0.02 1.72 T 0.02 0.363
Change at 1 yr j0.03 T 0.02 0.686 j0.01 T 0.03 0.686 0.686
Change at 2 yr j0.04 T 0.02 0.349 j0.01 T 0.03 0.686 0.686
Protein intake, absolute (gIdj1)
Baseline 87 T 2 87 T 3 0.973
Change at 1 yr j1 T 2 0.916 j1 T 2 0.916 0.916
Change at 2 yr j4 T 2 0.073 j7 T 2 0.017 0.916
Protein intake, relative (gIkg body massj1Idj1)
Baseline 1.20 T 0.02 1.21 T 0.04 0.951
Change at 1 yr +0.12 T 0.03 0.0001 j0.01 T 0.04 0.856 0.012
Change at 2 yr +0.06 T 0.03 0.062 j0.12 T 0.04 0.004 G0.001
Sample sizes at baseline, 1 yr, and 2 yr were 143, 130, and 120 for CR and 75, 71, and 71 for AL, respectively.







not related to absolute protein intake during the intervention
(r = j0.062, P = 0.502).
Aerobic capacity and physiologic responses to
maximal treadmill exercise. Table 2 presents aerobic
capacity results for participants who achieved V˙O2max: n =
195 at baseline (130 CR, 65 AL); n = 158 at 1 yr (101 CR,
57 AL); n = 141 at 2 yr (92 Cr, 49 AL). Treadmill exercise
time increased significantly in CR at 1 and 2 yr (baseline
13.0 T 0.2; 1 yr 14.3 T 0.3; 2 yr 14.6 T 0.3 min); the increases
were significant relative to AL at both time points (P G 0.001).
Absolute V˙O2max (LImin
j1), however, decreased significantly
in the CR group at 1 and 2 yr; a small nonsignificant decrement
was observed in AL at 2 yr. By contrast, V˙O2max expressed
relative to body mass increased significantly in CR subjects at
both time points relative to baseline and relative to AL. When
V˙O2max was expressed relative to lean body mass or lean leg
mass, no changes were observed from baseline to 1 yr or 2 yr
in the CR or AL group.
When the analyses were performed using absolute and
relative V˙O2peak (i.e., the single highest 15-s V˙O2 value)
instead of V˙O2max and included all participants who com-
pleted a treadmill test, the overall results and conclusions
were not different. Furthermore, changes in absolute and rel-
ative V˙O2max in response to 2 yr of CR did not differ between
participants who were normal weight or overweight at base-
line. Data on oxygen pulse, rate pressure product, HR, BP,
RER, and RPE at maximal exercise are presented in Table 2.
Sex differences in body mass and aerobic capacity in the
CR group are shown in Table 3. Men had higher body mass,
lean body mass, absolute V˙O2max, and relative V˙O2max
values than women at all time points (as expected). Absolute
V˙O2max and V˙O2max expressed relative to lean body mass
decreased significantly only among females in response to
CR. V˙O2max expressed relative to whole body mass tended
to increase more among CR males than females. Treadmill
test time increased significantly among females and males
at both time points; a statistically greater increase was
observerd among males after 2 yr of CR. Changes in other
exercise test variables in response to CR, such as oxygen
pulse at maximal exercise, rate pressure product, HRmax,
TABLE 2. Aerobic capacity and physiologic responses to maximal treadmill exercise in the CR and AL groups.
CR AL
Mean T SE Within-Group P Value Mean T SE Within-Group P Value Between-Group P Value
V˙O2max, absolute (LImin
j1)
Baseline 2.53 T 0.06 2.51 T 0.09 0.517
Change at 1 yr j0.14 T 0.03 G0.0001 0.00 T 0.03 0.895 G0.001
Change at 2 yr j0.15 T 0.03 G0.0001 j0.08 T 0.04 0.129 0.134
V˙O2max, relative to body mass (mLIkg body mass
j1Iminj1)
Baseline 34.8 T 0.6 34.8 T 1.0 0.996
Change at 1 yr +2.2 T 0.4 G0.0001 +0.2 T 0.5 0.648 0.004
Change at 2 yr +1.9 T 0.5 G0.001 j1.1 T 0.7 0.191 G0.001
V˙O2max, relative to lean body mass (mLIkg body mass
j1Iminj1)
Baseline 54.4 T 0.6 54.8 T 1.1 0.738
Change at 1 yr j0.78 T 0.54 0.453 +0.47 T 0.70 0.657 0.453
Change at 2 yr j1.05 T 0.59 0.381 j1.47 T 0.81 0.381 0.657
Oxygen pulse at maximal exercise (mL per beat)
Baseline 14.1 T 0.3 13.9 T 0.5 0.537
Change at 1 yr j0.65 T 0.15 0.0001 +0.04 T 0.19 0.848 0.006
Change at 2 yr j0.90 T 0.16 G0.0001 j0.32 T 0.21 0.241 0.045
Rate pressure product
Baseline 31,026 T 404 30,710 T 532 0.75
Change at 1 yr j2308 T 530 G0.0001 j323 T 655 0.621 0.003
Change at 2 yr j3850 T 1241 0.008 j3376 T 1356 0.038 0.621
Treadmill time (min)
Baseline 13.0 T 0.2 13.2 T 0.3 0.60
Change at 1 yr +0.7 T 0.1 G0.0001 j0.1 T 0.2 0.739 G0.001
Change at 2 yr +2.9 T 0.2 G0.0001 +1.8 T 0.2 G0.0001 G0.0001
HR at maximal exercise (bpm)
Baseline 185 T 1 185 T 1 0.94
Change at 1 yr j2 T 1 0.003 j1 T 1 0.630 0.630
Change at 2 yr j2 T 1 0.113 j0 T 1 0.642 0.630
Systolic blood pressure at maximal exercise (mm Hg)
Baseline 168 T 2 167 T 3 0.80
Change at 1 yr j10 T 3 G0.001 j1 T 3 0.710 0.005
Change at 2 yr j21 T 6 0.001 j17 T 6 0.017 0.569
Diastolic blood pressure at maximal exercise (mm Hg)
Baseline 77 T 1 77 T 2 0.52
Change at 1 yr j1 T 1 0.643 +1 T 2 0.643 0.643
Change at 2 yr j6 T 3 0.361 j8 T 4 0.140 0.643
RER at maximal exercise
Baseline 1.23 T 0.01 1.23 T 0.01 0.52
Change at 1 yr j0.01 T 0.01 0.499 j0.02 T 0.01 0.366 0.975
Change at 2 yr j0.00 T 0.01 0.975 +0.00 T 0.01 0.975 0.975
Borg RPE at maximal exercise
Baseline 18.0 T 0.2 18.0 T 0.2 0.93
Change at 1 yr +0.5 T 0.2 0.014 +0.3 T 0.2 0.357 0.585
Change at 2 yr +0.6 T 0.2 G0.001 +0.2 T 0.2 0.504 0.444
V˙O2max, maximal oxygen uptake. Table includes subjects who achieved V˙O2max. Sample sizes at baseline, 1 yr, and 2 yr were 130, 101, and 92 for CR and 65, 57, and 49 for AL, respectively.










maximal blood pressure, and peak RER, did not differ by
sex (data not shown).
Figures 1 and 2 show changes in V˙O2max (absolute and
relative, respectively) versus changes in body mass at 2 yr
for each CR and AL subject, by sex. The change in absolute
V˙O2max in the CR group from baseline to 2 yr did not cor-
relate with change in whole body mass (P = 0.569), whereas
there was a trend for a weak correlation with change in lean
body mass (r = 0.204, P = 0.055).
Muscle strength and muscle endurance. As shown
in Table 4, absolute knee extensor and knee flexor strength
declined significantly in response to CR; at 2 yr, however,
these changes were not statistically different than that in the
AL group. When expressed relative to body mass, knee ex-
tension and knee flexion torque generally increased in CR
compared with AL. No group differences were observed when
peak torque was expressed relative to leg lean mass (data not
shown). Muscle fatigue index increased comparably in CR
and AL at both time points.
Changes in absolute and relative strength measures in
response to 2 yr of CR did not differ between participants who
were normal weight or overweight at baseline. Knee extensor
and flexor strength measures by sex are shown in Table 3. All
strength values were greater for CR males than females,
whether expressed in absolute terms or relative to body mass
or leg lean mass. Additional sex differences were observed in
response to 2 yr of CR. Females had significant decreases in
absolute strength and strength expressed relative to leg lean
mass, whereas males did not. By contrast, males demonstrated
strength increases when expressed relative to body mass. Iso-
metric results were consistent with those of the isokinetic tests
(data not shown).
DISCUSSION
This is the first randomized controlled trial to investigate
the effects of long-term (i.e., 91 yr) CR on aerobic capacity
and muscle strength in nonobese humans. In our population
TABLE 3. Body mass, aerobic capacity, and muscle strength by sex in the CR group.
CR Females CR Males
Mean T SE Within-Sex P Value Mean T SE Within-Sex P Value Between-Sex P Value
Body mass (kg)
Baseline 67.7 T 0.6 81.6 T 1.2 G0.0001
Change at 2 yr j7.1 T 0.4 G0.0001 j8.5 T 0.7 G0.0001 0.136
Lean body mass (kg)
Baseline 40.9 T 0.4 57.5 T 0.9 G0.0001
Change at 2 yr j1.6 T 0.2 G0.0001 j3.2 T 0.4 G0.0001 0.003
V˙O2max, absolute (LImin
j1)
Baseline 2.19 T 0.04 3.22 T 0.07 G0.0001
Change at 2 yr j0.20 T 0.04 G0.0001 j0.09 T 0.06 0.180 0.180
V˙O2max, relative to body mass (mLIkg body mass
j1Iminj1)
Baseline 32.5 T 0.6 39.4 T 0.8 G0.0001
Change at 2 yr +0.9 T 0.6 0.146 +3.3 T 0.9 0.001 0.073
V˙O2max, relative to lean body mass (mLIkg lean body mass
j1Iminj1)
Baseline 53.7 T 0.8 55.9 T 1.0 0.024
Change at 2 yr j2.8 T 0.7 G0.001 +0.9 T 1.0 0.355 0.009
Treadmill time (min)
Baseline 12.2 T 0.2 14.5 T 0.3 G0.001
Change at 2 yr +2.3 T 0.2 G0.0001 +3.5 T 0.3 G0.0001 0.005
Isokinetic measures, absolute
Knee extension at 60-Isj1 (NIm)
Baseline 122 T 3 190 T 5 G0.0001
Change at 2 yr j19.5 T 2.5 G0.0001 +0.1 T 4.7 0.976 0.003
Knee extension at 180-Isj1 (NIm)
Baseline 79 T 2 128 T 4 G0.0001
Change at 2 yr j10.8 T 1.6 G0.0001 +4.9 T 2.9 0.191 0.0001
Knee flexion at 60-Isj1 (NIm)
Baseline 64 T 2 101 T 3 G0.0001
Change at 2 yr j5.9 T 1.3 G0.0001 j1.0 T 2.4 0.673 0.307
Knee flexion at 180-Isj1 (NIm)
Baseline 51 T 1 79 T 3 G0.0001
Change at 2 yr j6.6 T 1.1 G0.0001 +0.6 T 2.0 0.772 0.015
Isokinetic measures, relative to body mass
Knee extension at 60-Isj1 (NImIkg body massj1)
Baseline 1.81 T 0.04 2.33 T 0.06 G0.0001
Change at 2 yr j0.08 T 0.04 0.079 +0.24 T 0.06 0.0005 0.0001
Knee extension at 180-Isj1 (NImIkg body massj1)
Baseline 1.18 T 0.03 1.57 T 0.04 G0.0001
Change at 2 yr j0.00 T 0.02 0.864 +0.19 T 0.04 G0.0001 G0.001
Knee flexion at 60-Isj1 (NImIkg body massj1)
Baseline 0.94 T 0.02 1.24 T 0.04 G0.0001
Change at 2 yr +0.02 T 0.02 0.311 +0.12 T 0.03 0.002 0.065
Knee flexion at 180-Isj1 (NImIkg body massj1)
Baseline 0.76 T 0.02 0.97 T 0.03 G0.0001
Change at 2 yr j0.01 T 0.02 0.696 +0.10 T 0.03 0.0009 0.005
Sample sizes for V˙O2max at baseline and 2 yr were 97 and 60 for CR females and 43 and 32 for CR males, respectively.







of healthy adults, 2 yr of a modest CR diet resulted in dec-
rements in absolute V˙O2max and strength of the knee extensor
and flexor muscles, whereas increases in these parameters
were observed when expressed relative to body mass. Im-
portantly, CR participants exercised longer on the treadmill
and achieved a higher work rate after 2 yr of ~12% CR. This
demonstrates that despite significant reductions in lean body
mass, leg strength, and oxygen uptake at maximal exercise,
cardiorespiratory fitness was preserved.
V˙O2max is affected primarily by age, sex, and training
status in healthy individuals. The reduction in V˙O2max that
occurs with normal aging generally averages 10% per de-
cade, as observed in both cross-sectional and longitudinal
studies (9), but is highly variable between individuals. The
observed decrease in absolute V˙O2max (LImin
j1) at 2 yr in
our study exceeded the expected age-related decline of ap-
proximately 1% per year and was greater in CR than in AL.
Vigorous endurance exercise training has been shown to
attenuate the age-related decline in V˙O2max (8,26) but was
not part of the CR intervention.
Relative V˙O2max (mLIkg body mass
j1Iminj1), in contrast
to absolute V˙O2max, increased in response to CR. Males in our
study tended to increase relative V˙O2max to a greater extent
than females, which may be explained by the observation that
physical AEE was maintained in males, whereas it decreased
in females in response to CR. It is noteworthy that CR par-
ticipants achieved a higher work rate during the graded
treadmill test after 2 yr of CR, reaching stage 8 (4.2 mph, 16%
grade) at 2 yr, compared with stage 7 (3.8 mph, 16% grade) at
baseline. The AL group reached stage 7 at baseline and 2 yr.
Therefore, the increase in the CR group does not appear to be a
learning effect of repeated testing. Importantly, the American
College of Sports Medicine cardiorespiratory fitness categories
(1) are based on relative V˙O2max. There is no evidence of which
FIGURE 2—Change in relative maximal oxygen uptake (V˙O2max, mLIkg
j1Iminj1) in relation to change in whole body mass from baseline to 2 yr. CR
group (A); AL control group (B). Each symbol represents a single subject. Regression lines are shown for females (dashed lines) and males (solid lines).
CR females: R2 = 0.052, P = 0.049; CR males: R2 = 0.364, P G 0.0001; AL females: R2 = 0.299, P G 0.001; AL males: R2 = 0.374, P G 0.0001.
FIGURE 1—Change in absolute maximal oxygen uptake (V˙O2max, LImin
j1) in relation to change in whole body mass from baseline to 2 yr. CR group
(A); AL control group (B). Each symbol represents a single subject. Regression lines are shown for females (dashed lines) and males (solid lines). CR
females: R2 = 0.3350, P G 0.0001; CR males: R2 = 0.1172, P = 0.040; AL females: R2 = 0.0001, P = 0.957; AL males: R2 = 0.257, P = 0.007.










we are aware that a decrease in absolute V˙O2max without a de-
crease in relative V˙O2max is detrimental or has clinical implica-
tions with respect to cardiovascular health or mortality risk.
This is an important area of investigation for future CR studies.
The smaller body mass resulting from long-term CR may
enable greater economy of movement that likely offsets the
lower absolute V˙O2. Long-term CR studies in rhesus mon-
keys support this view (32). Another intriguing possibility is
that skeletal muscle mitochondrial adaptations may occur in
response to CR, as reviewed by Hepple (10). Specifically,
mitochondrial biogenesis is induced in response to CR in
rodents (17) and humans (5); this may be explained by per-
oxisome proliferator-activated receptor F coactivator 1> gene
expression in skeletal and cardiac muscle with CR, as dem-
onstrated in rodents (11). Peroxisome proliferator-activated
receptor F coactivator 1> is an inducible transcriptional coreg-
ulator of mitochondrial function that is activated in response to
exercise, cold exposure, and CR (2).
Consistent with the results of our CALERIE phase 1 study
(30), absolute muscle strength declined in response to CR in
TABLE 4. Muscle strength and muscle endurance in the CR and AL groups.
CR AL
Mean T SE Within-Group P Value Mean T SE Within-Group P Value Between-Group P Value
Isokinetic measures, absolute
Knee extension at 60-Isj1 (NIm)
Baseline 143 T 4 138 T 5 0.527
Change at 1 yr j10.9 T 1.7 G0.0001 j1.3 T 2.1 0.527 0.0004
Change at 2 yr j10.3 T 2.3 G0.0001 j7.2 T 2.7 0.023 0.527
Knee extension at 180-Isj1 (NIm)
Baseline 94 T 3 92 T 3 0.487
Change at 1 yr j6.2 T 1.1 G0.0001 j0.3 T 1.4 0.841 0.001
Change at 2 yr j3.2 T 1.4 0.084 j2.2 T 1.7 0.583 0.841
Knee flexion at 60-Isj1 (NIm)
Baseline 75 T 2 75 T 3 0.963
Change at 1 yr j4.4 T 1.1 0.0003 j1.6 T 1.4 0.333 0.318
Change at 2 yr j3.0 T 1.2 0.044 j1.4 T 1.4 0.333 0.333
Knee flexion at 180-Isj1 (NIm)
Baseline 60 T 2 59 T 2 0.751
Change at 1 yr j4.0 T 0.8 G0.0001 j1.1 T 1.1 0.602 0.088
Change at 2 yr j3.2 T 1.0 0.044 j0.4 T 1.2 0.744 0.123
Isokinetic measures, relative to body mass
Knee extension at 60-Isj1 (NImIkg body massj1)
Baseline 1.97 T 0.04 1.93 T 0.05 0.441
Change at 1 yr +0.08 T 0.03 0.008 j0.00 T 0.03 0.908 0.061
Change at 2 yr +0.07 T 0.03 0.061 j0.10 T 0.04 0.061 0.004
Knee extension at 180-Isj1 (NImIkg body massj1)
Baseline 1.30 T 0.03 1.27 T 0.03 0.543
Change at 1 yr +0.07 T 0.02 G0.0001 +0.00 T 0.02 0.926 0.015
Change at 2 yr +0.09 T 0.02 G0.0001 j0.03 T 0.03 0.396 0.0002
Knee flexion at 60-Isj1 (NImIkg body massj1)
Baseline 1.03 T 0.02 1.04 T 0.03 0.996
Change at 1 yr +0.06 T 0.02 0.0003 j0.01 T 0.02 0.544 0.005
Change at 2 yr +0.07 T 0.02 0.0002 j0.02 T 0.02 0.544 0.001
Knee flexion at 180-Isj1 (NImIkg body massj1)
Baseline 0.82 T 0.02 0.82 T 0.02 0.676
Change at 1 yr +0.04 T 0.01 0.005 j0.01 T 0.02 0.983 0.053
Change at 2 yr +0.05 T 0.01 0.005 j0.00 T 0.02 0.983 0.071
Isometric measures, absolute
Isometric knee extension at 45- (NIm)
Baseline 124 T 3 122 T 4 0.830
Change at 1 yr j5.0 T 1.8 0.0193 +2.7 T 2.3 0.274 0.019
Change at 2 yr j6.1 T 1.9 0.0104 j2.6 T 2.4 0.274 0.274
Isometric knee flexion at 45- (NIm)
Baseline 97 T 2 96 T 3 0.695
Change at 1 yr j5.6 T 1.3 G0.0001 j3.1 T 1.6 0.173 0.381
Change at 2 yr j6.3 T 1.6 0.0005 j4.9 T 2.0 0.048 0.552
Isometric measures, relative to body mass
Isometric knee extension at 45- (NImIkg body massj1)
Baseline 1.70 T 0.03 1.70 T 0.05 0.666
Change at 1 yr +0.13 T 0.03 G0.0001 +0.05 T 0.03 0.295 0.112
Change at 2 yr +0.09 T 0.03 0.0102 j0.04 T 0.04 0.295 0.014
Isometric knee flexion at 45- (NImIkg body massj1)
Baseline 1.33 T 0.03 1.33 T 0.03 0.949
Change at 1 yr +0.09 T 0.02 G0.0001 j0.03 T 0.02 0.182 G0.0001
Change at 2 yr +0.07 T 0.02 0.014 j0.06 T 0.03 0.087 0.001
Muscle endurance
Work fatigue index (%), average of knee flexion and extension at 180-Isj1
Baseline 28.9 T 1.2 29.7 T 1.5 0.69
Change at 1 yr +3.1 T 0.7 G0.0001 +4.2 T 0.9 G0.0001 0.482
Change at 2 yr +3.8 T 0.8 G0.0001 +2.9 T 1.1 0.019 0.482
Values for knee extension and flexion represent peak torque, averaged across the right and left legs. Sample sizes at baseline, 1 yr, and 2 yr were 141, 128, and 114 for CR and 72, 67,
and 65 for AL, respectively.







the current study, whereas muscle strength expressed relative
to body weight increased. The current multicenter CALERIE
2 results build upon the findings of the earlier, single-center
report in which CR was compared with an exercise-induced
energy deficit (30). Distinct characteristics of the CALERIE 2
study design include the longer duration of the CR interven-
tion (2 vs 1 yr), greater %CR prescribed (25% vs 16%–20%),
younger age range of participants (21–50 vs 50–60 yr), larger
study sample size (218 vs 34), and a larger sample of CR par-
ticipants (143 vs 18). The clinical significance of the observed
decrements in absolute strength in these studies is unclear. In
the absence of sex- and age-specific muscle strength reference
values and their associations with long-term health outcomes,
it is difficult to predict whether such changes are deleterious
with respect to functional capacity and disease risk. A decline
in absolute strength is to be expected after 2 yr of a CR in-
tervention that does not include resistance training; future CR
studies should include a structured resistance training com-
ponent to evaluate its potential in preserving lean body mass
and absolute strength.
Interestingly, the changes in strength in response to 2 yr
of CR differed significantly by sex, with only the female CR
participants demonstrating a decline in absolute strength and
only the male participants demonstrating an increase in strength
expressed relative to body weight. The explanation for this
finding is unclear, particularly in light of the greater loss of
lean body mass among male participants. There were no sig-
nificant relationships observed between changes in absolute
leg strength and changes in lean body mass or whole body
mass at 2 yr in the overall sample. Likewise, dietary protein
did not appear to influence the changes in lean body mass or
muscle strength at 2 yr.
A notable limitation of this study is that the average level of
CR achieved was substantially less than the 25% prescribed,
despite frequent contact and encouragement by research
personnel. Therefore, we are unable to determine whether
25% CR would result in deleterious changes in V˙O2max or
muscle strength that might impair cardiorespiratory or func-
tional capacity. Additional factors that may have influenced
our results include differences in participant demographics at
the three clinical sites and variability in diet composition and
diet quality among participants. Furthermore, some subjects
were unable to complete the V˙O2max or muscle strength tests
for orthopedic reasons, some did not meet the criteria for
achieving V˙O2max, and others dropped out of the study.
Strengths of the CALERIE 2 trial include a relatively large
and diverse sample of individuals from three distinct regions of
the United States, a long-term CR intervention, common pro-
tocols for the CR intervention and all assessments, and a high
degree of quality control.
In summary, we observed that 2 yr of CR in nonobese,
healthy, young, and middle-age adults resulted in higher
relative aerobic capacity, despite significant reductions in
absolute V˙O2max, absolute strength, whole body mass, lean
body mass, and leg lean mass. In addition, treadmill exercise
time and work rate increased after 2 yr of CR, suggesting that
long-term, modest CR with adequate nutrient intake does not
adversely affect cardiorespiratory function in healthy adults.
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